8-K: HealthLynked Strengthens Leadership for Nasdaq Uplisting & Growth

HealthLynked Corp. announced key executive and board appointments, including a new COO and two directors, to bolster its strategic initiatives for national expansion and a Nasdaq uplisting.

Summary

• Duncan McGillivray was appointed as Chief Operating Officer (COO), effective December 8, 2025, bringing over 30 years of executive leadership in healthcare, technology, capital markets, and project finance.
• Jason Bishara was appointed to the Board of Directors, effective December 1, 2025, adding over 25 years of experience in investment banking, fintech innovation, and insurance-based risk management.
• Chris G. Pulos was appointed to the Board of Directors, effective December 1, 2025, contributing over 42 years of executive experience in corporate benefits and insurance strategies.
• The Board of Directors increased its size from six members to eight members to accommodate the new appointments.
• The company is actively pursuing an uplisting to the Nasdaq Capital Market, with the COO's compensation structured to incentivize this goal.
• Strategic focus includes expanding partnerships with major insurers, employer groups, and Accountable Care Organizations (ACOs).
• The company plans to deploy ARI, its patented AI healthcare guide developed with OpenAI, and advance national initiatives like the Kill the Clipboard movement and the federal Genesis Mission AI acceleration effort.
• Efforts are underway to scale the platform of healthcare providers in the US, aiming to serve more than one million users.

Sentiment

Score: 8

Explanation: The filing announces significant strengthening of the executive team and board with highly experienced individuals, directly supporting the company's ambitious strategic goals of national expansion, AI platform deployment, and a Nasdaq uplisting. This indicates strong forward momentum and a clear strategic direction.

Positives

• Appointment of Duncan McGillivray as COO brings extensive experience in capital markets, project finance (advising on over $1 billion in projects), and healthcare operations, crucial for national expansion and Nasdaq uplisting.
• Jason Bishara's addition to the Board provides deep expertise in risk management, capital markets, and fintech, essential for navigating AI-driven healthcare transformation.
• Chris G. Pulos's appointment to the Board strengthens expertise in employer benefits, value-based healthcare strategies, and cost containment, aligning with the company's goals for payer and employer partnerships.
• The increase in board size and the caliber of new directors enhance corporate governance and strategic oversight.
• The COO's compensation structure, including a base salary increase from $120,000 to $150,000 and 90,000 restricted stock units, is directly tied to the successful Nasdaq uplisting, aligning management incentives with shareholder value.
• The company's clear strategic direction towards AI-driven care coordination, interoperability, and national expansion positions it for significant growth in the evolving healthcare market.

Risks

• Forward-looking statements are inherently uncertain and may differ materially from actual results.
• Forward-looking statements are subject to risks, uncertainties, and assumptions.
• HealthLynked disclaims any obligation to update these statements except as required by law.

Future Outlook

The company plans to expand partnerships with major insurers, employer groups, and Accountable Care Organizations (ACOs), deploy its AI healthcare guide ARI, advance national initiatives like the Kill the Clipboard movement and 21st Century Cures Act interoperability mandates, scale its platform to serve over one million users, and complete its listing to the Nasdaq Capital Market in 2026.

Management Comments

• Dr. Michael Dent (CEO): "Chris's expertise in how employer groups and payers structure and fund healthcare delivery is invaluable as we expand partnerships with insurers and Accountable Care Organizations."
• Dr. Michael Dent (CEO): "Jason's experience at the intersection of insurance, and technology is a perfect fit for where HealthLynked is heading."
• Dr. Michael Dent (CEO): "With Duncan's combination of operational leadership, healthcare expertise, and sophisticated capital markets experience, HealthLynked is significantly strengthening its executive team at a pivotal time."
• Chris G. Pulos: "HealthLynked is solving one of healthcare's biggest problems—connecting patients, providers, and payers with real-time data and AI."
• Jason Bishara: "I'm thrilled to join the Board at a time when HealthLynked is scaling nationwide."
• Duncan McGillivray: "I'm excited to join HealthLynked at a moment when AI, interoperability, and consumer-driven platforms are reshaping the future of healthcare."

Industry Context

The appointments align with broader industry trends towards AI-driven healthcare, interoperability, value-based care, and cost containment. The company is positioning itself to capitalize on mandates like the 21st Century Cures Act and federal AI acceleration efforts (Genesis Mission). The focus on connecting patients, providers, and payers with real-time data and AI addresses a significant industry challenge, aiming to improve outcomes and reduce costs.

Comparison to Industry Standards

• NSI Insurance Group, where Mr. Bishara serves, is one of the five largest privately held insurance agencies in the United States, operating in all 50 states and over 100 countries, indicating his experience with a significant industry player.
• Marsh McLennan Agency, where Mr. Pulos serves, is described as one of the world's largest employee benefits advisory firms, highlighting his experience with a leading global firm.
• Mr. McGillivray's experience includes working with the U.S. Department of Health (HRSA) and its national cooperative partner Capital Link, which guides the nation's approximately 1,400 Federally Qualified Health Centers, demonstrating engagement with a key segment of the U.S. healthcare system.

Management Changes

Corporate Governance

Stakeholder Impact

• **Shareholders:** Potential positive impact from strengthened leadership, strategic growth initiatives, and planned Nasdaq uplisting, which could enhance liquidity and valuation.
• **Employees:** New COO appointment could lead to operational restructuring or new strategic directions, potentially creating new opportunities or changes in roles.
• **Customers (Patients/Providers/Payers):** Enhanced care coordination, reduced costs, and improved access through AI-driven platforms and expanded partnerships, leading to better healthcare outcomes.
• **Creditors:** Potential positive impact from improved financial management and capital formation strategies under the new COO, potentially enhancing the company's financial stability and ability to meet obligations.

Next Steps

• Expand partnerships with major insurers, employer groups, and Accountable Care Organizations (ACOs).
• Deploy ARI, the patented AI healthcare guide.
• Advance national initiatives such as the Kill the Clipboard movement, the 21st Century Cures Act interoperability mandates, and the federal Genesis Mission AI acceleration effort.
• Scale its platform of healthcare providers in the US and serving more than one million users.
• Complete its listing to Nasdaq Capital Markets in 2026.
• Duncan McGillivray to drive operational scale-up, support national payer and employer partnerships, and lead capital formation and banking relations.

Key Dates

Recommendation

The strategic appointments of a highly experienced COO and two seasoned directors, coupled with clear objectives for national expansion, AI platform deployment, and a Nasdaq uplisting, signal a strong commitment to growth and value creation. The alignment of executive compensation with the uplisting goal further reinforces this positive outlook. These moves significantly strengthen the company's operational and governance capabilities, positioning it for substantial future development in the rapidly evolving healthcare technology sector.

Keywords

Healthcare technology, AI, care coordination, Nasdaq uplisting, executive appointments, board of directors, health insurance, fintech, digital health, risk management, corporate governance